BA
AZN icon

BlackRock Advisors’s AstraZeneca AZN Stock Holding History

BlackRock Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,500
Closed -$250K – 3695
2014
Q3 		$250K Buy
+3,500
New +$256K ﹤0.01% 2469

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BlackRock Advisors's AZN Position: Q4 2016 in Review

BlackRock Advisors reduced its AstraZeneca (AZN) stake by 94% in Q4 2016, selling an estimated $57.6M and leaving 64,000 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1279.

BlackRock Advisors first reported a position in AZN in Q2 2013 and has held it in 15 quarters since. The position peaked at $135M in Q1 2014. 449 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • BlackRock Advisors held 64,000 shares of AstraZeneca worth $3.5M as of Q4 2016.
  • BlackRock Advisors sold 1,014,863 AstraZeneca shares in Q4 2016, an estimated $57.6M.
  • AstraZeneca made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1279 holding.
  • BlackRock Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's AstraZeneca position peaked at $135M in Q1 2014.
  • 449 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.